Infection and Vaccines金沙正规投注官网
金沙登录网址
金沙正规投注官网
金沙登录网址
We work to protect patients against the burden of influenza, respiratory syncytial virus (RSV) and bacterial infections, particularly those resistant to current antibiotics.
In Europe, antimicrobial resistance results in 25,000 deaths from hospital-acquired infections, while there are 3-5 million severe cases of influenza each year worldwide. RSV disease is the leading cause of hospitalisation in children under one year of age in the United States
Demand for health interventions to address these burdens of disease remains high and, through working with the wider infection community, AstraZeneca aims to translate science into solutions to address global challenges faced in these disease areas.
金沙登录网址
Infectious diseases are the second-leading cause of death worldwide, after heart disease, and are responsible for 更多 deaths annually than cancer.
-
金沙正规投注官网
AMR is a major public health threat. As bacteria develop resistance to current antibiotics, deadly infections could, again, become uncontrollable.
-
金沙正规投注官网
Seasonal influenza is a serious public health problem that causes severe illness and death in high-risk populations.
金沙正规投注官网
金沙正规投注官网
金沙正规投注官网
金沙正规投注官网
金沙正规投注官网
金沙正规投注官网
金沙正规投注官网
金沙正规投注官网
金沙登录网址
We cannot provide 详细ed 资讯rmation 关于 our prescription medicines on this website, in compliance with regulations. Our medicines are approved in individual countries for specific uses and the 资讯rmation we provide for patients is governed by local regulations. In some cases, health care professionals and patients can visit local AstraZeneca websites to find out 更多 关于 our medicines. Please note that in some countries we are not allowed to provide very much, or sometimes any, 资讯rmation on our prescription medicines so you should seek alternative trustworthy sources. Always ask a healthcare professional for advice 关于 medicines.
Synagis 金沙正规投注官网
palivizumab
Fluenz Tetra/FluMist Quadrivalent金沙正规投注官网
influenza vaccine live, intra-nasal
金沙登录网址
金沙登录网址
We publish information about the registration and results of all new and ongoing clinical trials for all products in all phases on our dedicated website.
金沙登录网址
Our medicines are approved in individual countries for specific uses. Visit your local AstraZeneca site to find out more
金沙登录网址
and help us deliver life-changing medicines
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.
Veeva ID: Z4-17493
Date of next review: 07/06/2021